Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 9–9 | Cite as

Pancreatitis or pancreatic cancer with DPP-4 inhibitors

Clinical study
  • 32 Downloads

Reference

  1. Lee M, et al. Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase-4 Inhibitors. Diabetes Care : 20 Aug 2019. Available from: URL: https://doi.org/10.2337/dc18-2195

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations